The British Pharmacopoeia is the national pharmacopoeia of the UK and is published annually. It contains quality standards for UK medicinal substances and includes monographs on ingredients, preparations, packaging and other requirements. It has multiple volumes covering medicinal substances, formulated preparations, appendices and indices. The appendices provide information on interactions, borderline substances, cautionary labels and wound management products. It is used by healthcare professionals in the UK as an official reference for pharmaceutical substances and preparations.

1. British
pharmacopoeia
Appendices

2. Pharmacopoeia, Monogragh
• An official publication containing a list of medicinal drugs
with their effects and directions for their use.
• A pharmacopoeia, pharmacopeia, or pharmacopoea (“drug-
making standard”), is a book containing directions for the
identification of compound medicines, and published by the
authority of a government or a medical or pharmaceutical
society.
• A monograph includes the name of ingredients or
preparations; the definition, packaging, storage and labeling
requirements and requirements. The specification consists
of a series of tests, procedures for tests, and acceptance
criteria.

3. British pharmacopeia
• The British Pharmacopoeia (BP) is the national
pharmacopoeia of the United Kingdom. It is an
annually published collection of quality standards
for UK medicinal substances.
• It is a non-profit organisation that owns the
trademark and copyright.
• Latest edition:
• The BP 2020 is the latest edition of the British
Pharmacopoeia. This edition becomes legally
effective from 1 January 2020.

4. Editions of British
pharmacopeia

11. Volumes
• Volumes I and II
• Medicinal Substances
• Volume III
• Formulated Preparations
• Blood related Preparations
• Immunological Products
• Radiopharmaceutical Preparations
• Surgical Materials
• Homeopathic Preparations
• Volume IV
• Appendices
• Infrared Reference Spectra
• Index
• Volume V
• British Pharmacopoeia (Veterinary)
• Volume VI
• (CD-ROM version)
• British Pharmacopoeia
• British Pharmacopoeia (Veterinary)
• British Approved Names

12. Appendices and indices
Appendix 1: Interactions
Appendix 2: Borderline substances
Appendix 3: Cautionary and advisory labels for diapensed
medicines
Appendix 4: wound management products and
elasticated garments
• Dental practitioners' formulary
• Nurse prescribers' formulary
• Non-medical prescribing
• Special order manufacturers

13. Borderline substances
• Borderline substances are mainly foodstuffs, such as enteral feeds and
foods that are specially formulated for people with medical conditions.
• The Committee has recommended a number of products as complete
feeds for certain conditions.They may be prescribed both as sole sources
of nutrition and as necessary nutritional supplements prescribable on
medical grounds.
 Definitions
1. The Committee has defined proven lactose or sucrose intolerance as "A
condition of intolerance to an intake of the relevant disaccharide
confirmed by:
2. The Committee has defined proven whole protein sensitivity as
"Intolerance to whole protein, proven by at least two withdrawal and
challenge tests, as suggested by an accurate dietary history."

14. Cautionary and advisory labels(CALs for
diapensed medicines

18. wound management products and
elasticated garments
Cotton Absorbent cotton BP
Lint Absorbent lint BPC
Wound drainage pouches Biotrol draina S
Alginate dressings Sorbalgon
Hydrogel application Aquaform
Odour absorbent dressings CarboFLEX
Iodine dressings Iodosorb ointment
Permeable adhesive tapes Zinc oxide adhesive tape BP 1988

19. Dental and nurse prescribers'
formulary
• Aciclovir Cream BP
• Benzydamine Mouthwash, BP 0.15%
• Carbamazepine Tablets BP
• Diazepam Oral Solution BP 2mg/5ml
• Ephedrine Nasal Drops BP
• Fluconazole Oral Suspension 50mg/5ml DPF
• Hydrocortisone Cream BP 1%
• Ibuprofen Tablets BP
• Lansoprazole Capsules DPF
• Tetracycline Tablets BP

20. Non-medical prescribing

21. Special order manufacturers
• Licensed hospital manufacturing units also
manufacture ‘special-order’ products as unlicensed
medicines, the principal NHS units
• The MHRA recommends that an unlicensed
medicine should only be used when a patient has
special requirements that cannot be met by use of
a licensed medicine.